以“老视诊疗”与“屈光白内障”为核心，共塑屈光精准诊疗新标杆【2025年9月5日，杭州】在备受瞩目的中华医学会第二十九次眼科学术大会（CCOS2025）上，全球眼健康领域的引领者强生眼力健与国内领先的眼科医疗服务集团，朝聚眼科医疗控股（以下简称“朝聚眼科”，股票代码：2219.HK）的战略合作迈入全新阶段。会上，伴随2025年度战略合作协议的正式签署，双方将携手共建的“老视诊疗中心战略合作集团”与...
Source Link以“老视诊疗”与“屈光白内障”为核心，共塑屈光精准诊疗新标杆【2025年9月5日，杭州】在备受瞩目的中华医学会第二十九次眼科学术大会（CCOS2025）上，全球眼健康领域的引领者强生眼力健与国内领先的眼科医疗服务集团，朝聚眼科医疗控股（以下简称“朝聚眼科”，股票代码：2219.HK）的战略合作迈入全新阶段。会上，伴随2025年度战略合作协议的正式签署，双方将携手共建的“老视诊疗中心战略合作集团”与...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.